As such, intranasal administration improves cognition in healthy individuals (Benedictet al., 2004), raising the possibility that the reverse is also true; that is, decreased insulin signaling associated with sub-clinical insulin resistance accounts for the cognitive dysfunction observed following a HFD or obesity in otherwise healthy individuals. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.